Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab

Abstract Background Although a recent randomized clinical trial has demonstrated that the objective response rate to nivolumab for metastatic gastric cancer was 11.2%, there was no patients confirmed complete response. Herein, we report on a case of liver metastasis arising from early gastric cancer...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tsutomu Namikawa, Nobuko Ishida, Sachi Tsuda, Kazune Fujisawa, Eri Munekage, Jun Iwabu, Masaya Munekage, Sunao Uemura, Shigehiro Tsujii, Hiromichi Maeda, Hiroyuki Kitagawa, Michiya Kobayashi, Kazuhiro Hanazaki
Format: Artigo
Idioma:Inglês
Publicat: Japan Surgical Society 2018-07-01
Col·lecció:Surgical Case Reports
Matèries:
Gastric cancer
Nivolumab
Complete response
Chemotherapy
Biomarker
Accés en línia:http://link.springer.com/article/10.1186/s40792-018-0479-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars